Please login to the form below

Not currently logged in
Email:
Password:

lidocaine

This page shows the latest lidocaine news and features for those working in and with pharma, biotech and healthcare.

Fresenius says Akorn investigation could affect takeover

Fresenius says Akorn investigation could affect takeover

The revenue decline came in part because Akorn lost patent protection for ephedrine sulfate injection and lidocaine ointment products, but it has also suffered supply disruptions after the FDA found problems

Latest news

More from news
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Deal Watch June 2016 Deal Watch June 2016

    Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and Diprivan (propofol), a short acting intravenous sedative/ anaesthetic.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics